🔎 Trials Near Me

Home › Cancro del polmone non a piccole cellule › West Virginia

Studi clinici su Cancro del polmone non a piccole cellule nello stato di West Virginia

14 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi nello stato di West Virginia.

Città nello stato di West Virginia

Testo ufficiale dello studio (inglese)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • United Hospital Center, Bridgeport
  • Edwards Comprehensive Cancer Center, Huntington
  • West Virginia University Healthcare, Morgantown
  • e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04267848

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  • West Virginia University ( Site 3237), Morgantown
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07513376

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Edwards Comprehensive Cancer Center, Huntington
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06498635

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

  • Charleston Area Medical Center (CAMC), Charleston
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07361510

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

  • Research Site, Charleston
  • Research Site, Morgantown
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06868277

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • West Virginia University Hospitals - Mary Babb Randolph Cancer Center, Morgantown
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06712316

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

  • Research Site, Morgantown
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07291037

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Edwards Comprehensive Cancer Center, Huntington
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

  • Edwards Comprehensive Cancer Center, Huntington
  • West Virginia University Healthcare, Morgantown
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 mag 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Edwards Comprehensive Cancer Center, Huntington
  • West Virginia University Healthcare, Morgantown
In reclutamentoFase 2
18 Minutes · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • United Hospital Center, Bridgeport
  • Edwards Comprehensive Cancer Center, Huntington
  • WVUH-Berkely Medical Center, Martinsburg
  • e altri 3
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Edwards Comprehensive Cancer Center, Huntington
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Morgantown
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774

Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers

  • West Virginia University, Morgantown
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 nov 2024 · NCT06626243

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.